60 Degrees Pharmaceuticals, Inc.
SXTP
$0.97
-$0.01-0.68%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.60% | 7.61% | 8.24% | 5.32% | 48.24% |
| Total Depreciation and Amortization | 15.74% | 17.26% | 5.66% | 8.16% | 33.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 57.92% | 20.45% | 5.24% | -76.38% | -73.55% |
| Change in Net Operating Assets | -446.42% | -43.44% | -62.77% | 182.92% | -219.35% |
| Cash from Operations | -45.45% | 9.22% | 2.49% | 2.56% | -41.49% |
| Capital Expenditure | 78.86% | -1,651.85% | -- | 100.00% | 84.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -252.27% | -100.26% | 81,300.00% | 99.88% | -4,168.23% |
| Cash from Investing | 50.68% | -103.04% | 81,171.43% | 99.88% | -1,237.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | 102,786.00% |
| Repurchase of Common Stock | -- | 100.00% | 82.20% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 1,630.51% | 200.00% |
| Cash from Financing | -- | -100.00% | 169,590.00% | -99.98% | 572,344.44% |
| Foreign Exchange rate Adjustments | -93.02% | 273.74% | -395.00% | -211.11% | 20.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 244.74% | -182.84% | 209.19% | -195.20% | 230.80% |